Cardiometabolic Health Congress

AUGUST 14, 2024

Real-World Cardiorenal Metabolic Management Cases Case Study 1: The Multidisciplinary Advantage A groundbreaking study compared outcomes between multi-ethnic patients treated by a multidisciplinary team (MDT) and those managed solely by primary care providers (PCPs).

Education 52

Education Innovation Reimbursement Cardiovascular Disease 52

Stroke Journal

FEBRUARY 1, 2024

The primary outcome was incident ischemic stroke. Participants with LVI were significantly older, male, Black, had higher BMI, and lower HDL. There was no significant difference in history of cardiovascular disease events (6% versus 4%, p=0.143). with LVI, n=2,282 or 88.3% without LVI).

Atherosclerosis 40

Atherosclerosis Stroke Strokes Atrial Fibrillation 40

Dr. Paddy Barrett

OCTOBER 31, 2023

If you separate those with a significantly elevated Lp(a) (>50mg/dl) and a normal Lp(a) by levels of healthy lifestyle, you see major differences in outcomes. Better lifestyle factors significantly reduced the risk of coronary artery disease, but even with an optimal lifestyle pattern, there was a small increase in risk 2.

Coronary Artery Disease 52

Coronary Artery Disease Heart Disease Atherosclerosis Cardiovascular Disease 52

Physiologically Speaking

JANUARY 26, 2024

However, there’s not great evidence that multivitamins benefit specific health outcomes. This hypothesis was studied in a randomized controlled trial known as the COcoa Supplement and Multivitamin Outcomes Study or COSMOS. Nutritional insurance? A health- and longevity-boosting powerhouse? Perhaps not.

Physiology 52

Physiology Diet Cardiovascular Disease BMI 52

DAIC

FEBRUARY 1, 2024

The HEART Study is the world's first clinical trial investigating the use of genomic 'polygenic risk score (PRS) testing' to support the prevention of cardiovascular disease ( CVD ) in National Health Service (NHS) clinical practice. Prevention is at the heart of what we do as GPs and risk assessment underpins that.

Cardiovascular Disease 110

Cardiovascular Disease Risk Factors Best Practices Cholesterol 110

DAIC

JUNE 25, 2024

HHNM will use the Allia IGS Pulse system in its cardiac electrophysiology (EP) lab to plan, guide and monitor the outcomes of electrophysiological procedures, such as cardiac ablations, cardiac catherizations, transcatheter aortic valve replacements, balloon and coronary angioplasties and more. “We It’s an honor to have the U.S.’s

Electrophysiology 105

Electrophysiology Hospital Aortic valve Heart Disease 105

Cardiometabolic Health Congress

JULY 25, 2023

There are significant data that show that if you have obesity, you have a high risk of developing coronary heart disease, heart failure, type 2 diabetes (T2D) or risk factors such as hypertension and dyslipidemia. [1] These individuals tend to have a better prognosis when compared to both individuals with normal weight (BMI of 18.5

Obesity 52

Obesity BMI Heart Failure Cardiovascular Disease 52

DAIC

APRIL 24, 2024

Among participants with baseline body mass index (BMI) above 30 kg/m2, 70.4% Research shows that a 10 point reduction in systolic blood pressure helps lower the risk of coronary heart disease (17%), stroke (27%), heart failure (28%), and all-cause mortality (13%). Eighty percent of heart attacks and strokes are preventable.

Blood Pressure 116

Blood Pressure Cholesterol Technology Heart Attack 116

European Journal of Heart Failure

DECEMBER 18, 2024

Association between body mass index (BMI) and clinical outcomes in PARADISE-MI. ( A ) Histogram for BMI (kg/m 2 ), ( B ) adverse events for BMI subgroups, and spline model curves for ( C ) the primary composite outcome and ( D ) cardiovascular (CV) death by BMI subgroups.

Myocardial Infarction 40

Myocardial Infarction BMI Outcomes Heart Failure 40

Stroke Journal

FEBRUARY 1, 2024

Background:Obesity has been associated with an increase in the risk of stroke and poor outcomes. Patients were categorized into a metabolically healthy obese MHO+ve cohort, BMI> 30, and MHO-ve cohort, BMI<30. Stroke, Volume 55, Issue Suppl_1 , Page ATP262-ATP262, February 1, 2024.

Obesity 40

Obesity Hospital Stroke Strokes 40

Dr. Paddy Barrett

MARCH 23, 2024

They get the diseases of ageing about 20 to 25 years later than everyone else. It’s not that they don’t get cardiovascular disease, cancer or dementia; they just get it way later than everyone else. Most adults, healthy centenarians included, will die from one of three things: Cardiovascular Disease.

Chronic Disease 106

Chronic Disease Quality of Life Dementia Cancer 106

DAIC

MAY 21, 2024

The study, “Comprehensive Cardiovascular Risk Factor Control with a Mobile Health Cardiovascular Risk Self-Management Program,” highlights the potential use of digital health technology in the comprehensive control of risk factors for cardiovascular disease (CVD), the leading cause of death and disability in the United States.

Blood Pressure 52

Blood Pressure Cholesterol Risk Factors BMI 52

Physiologically Speaking

DECEMBER 15, 2023

But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovascular diseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Physiologically Speaking

DECEMBER 15, 2023

But resistance training hasn’t been the focus when it comes to improving cardiovascular health and preventing/reversing cardiovascular diseases (CVDs) — that honor goes to aerobic exercise training, for which the cardiovascular benefits are well-established and vast. The answer is yes.

Physiology 52

Physiology Exercise Blood Pressure Risk Factors 52

Dr. Paddy Barrett

AUGUST 29, 2023

Share JUPITER In 2008 a landmark paper was published showing that in people without cardiovascular disease and relatively normal LDL-cholesterol (<3.4 mmol/l or 130 mg/dl), the use of rosuvastatin 20mg significantly reduced the likelihood of major cardiovascular events 1. Circ Cardiovasc Qual Outcomes. What To Do?

Diabetes 52

Diabetes Risk Factors Heart Attack Heart attacks 52

Dr. Paddy Barrett

JANUARY 16, 2024

Cardiovascular disease, cancer and dementia account for 60% of all deaths in the US. And less diabetes means less of a driver of the three main leading causes of death - cardiovascular disease, cancer and dementia. Subscribe now 1 Life's Essential 8 and risk of non-communicable chronic diseases: Outcome-wide analyses.

Cancer 97

Cancer Dementia Diabetes Cardiovascular Disease 97

DAIC

MARCH 5, 2024

We've known for a long time that smoking tobacco is linked to heart disease, and this study is evidence that smoking cannabis appears to also be a risk factor for cardiovascular disease, which is the leading cause of death in the United States,” Jeffers said.

Heart Attack 98

Heart Attack Heart attacks Stroke Strokes 98

DAIC

MARCH 8, 2024

The FDA decision is based on the results of the landmark SELECT phase 3 cardiovascular outcomes trial that examined the effect of adding Wegovy 2.4 mg or placebo to cardiovascular standard of care in adults with overweight and obesity with established CVD and without diabetes. 1,2 The primary composite outcome occurred in 6.5%

Obesity 111

Obesity Heart Disease Heart Attack Heart attacks 111

Cardiometabolic Health Congress

OCTOBER 30, 2024

Case Study: A Common Clinical Scenario This case study highlights the complex relationship between metabolic disease and liver health. This underscores the importance of early detection and management of both conditions to prevent severe outcomes.

Diabetes 93

Diabetes Exercise Obesity BMI 93